14.9. Analysis.
Comparison 14 Efficacy at three years: etanercept + disease‐modifying anti‐rheumatic drug (DMARD) vs. etanercept, Outcome 9 No progression of joint damage (TSS ≤ 0.5).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.